Sancuso 3.1 MG/Day Weekly Transdermal Patch

RxCUI: 825005
RxNorm name: Sancuso 3.1 MG/Day Weekly Transdermal Patch
Display name: Sancuso 3.1 MG/Day Weekly Transdermal Patch
Full name: Sancuso 3.1 MG/Day Weekly Transdermal Patch
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SANCUSO	GRANISETRON	Cumberland Pharmaceuticals Inc.	7379369a-03df-4ec3-8f2e-66645cc736d8	2024-11-04	Warnings, Adverse reactions	Exact identifier rxcui: 825005

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
9aed2020-1827-4f13-99df-191c492c11f9	Sancuso 3.1 MG/Day 7 Day Transdermal System [PSN] · 168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso] [SBD] · 168 HR Sancuso 0.129 MG/HR Transdermal System [SY] · Sancuso 3.1 MG/Day 7 Day Transdermal System [SY] · Sancuso 3.1 MG/Day Weekly Transdermal Patch [SY]	5	5	These highlights do not include all the information needed to use Sancuso (Granisetron Transdermal System) safely and effectively. See full prescribing information for Sancuso. Sancuso (Granisetron Transdermal System) Initial U.S. Approval: 2008	20090930
7379369a-03df-4ec3-8f2e-66645cc736d8	Sancuso 3.1 MG/Day 7 Day Transdermal System [PSN] · 168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso] [SBD] · 168 HR Sancuso 0.129 MG/HR Transdermal System [SY] · Sancuso 3.1 MG/Day 7 Day Transdermal System [SY] · Sancuso 3.1 MG/Day Weekly Transdermal Patch [SY]	5	4	These highlights do not include all the information needed to use SANCUSO safely and effectively. See full prescribing information for SANCUSO. SANCUSO (granisetron transdermal system) Initial U.S. Approval: 2008	20241104